Clinical proteomics in obstetrics and neonatology

References

• Lumley J. Defining the problem: the epidemiology of preterm birth. BJOG 2003;110(Suppl 20):3-7
   PubMed Web of Science ®Google Scholar
• Malone FD, Canick JA, Ball RH, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005;353(19):2001-11
   PubMed Web of Science ®Google Scholar
• Snijders RJ, Noble P, Sebire N, et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998;352(9125):343-6
   PubMed Web of Science ®Google Scholar
• Makrigiannakis A, Karamouti M, Drakakis P, et al. Fetomaternal immunotolerance. Am J Reproduct Immunol 2008;60(6):482-96
   PubMed Web of Science ®Google Scholar
• Herr F, Baal N, Zygmunt M. Studies of placental vasculogenesis: a way to understand pregnancy pathology? Z Geburtshilfe Neonatol 2009;213(3):96-100
   PubMedGoogle Scholar
• Malassine A, Cronier L. Hormones and human trophoblast differentiation: a review. Endocrine 2002;19(1):3-11
   PubMedGoogle Scholar
• Shankar R, Cullinane F, Brennecke SP, Moses EK. Applications of proteomic methodologies to human pregnancy research: a growing gestation approaching delivery? Proteomics 2004;4(7):1909-17
   PubMedGoogle Scholar
• Kim YS, Kim MS, Lee SH, et al. Proteomic analysis of recurrent spontaneous abortion: identification of an inadequately expressed set of proteins in human follicular fluid. Proteomics 2006;6(11):3445-54
   PubMedGoogle Scholar
• Brewis IA. Proteomics in reproductive research: the potential importance of proteomics to research in reproduction. Hum Reprod 1999;14(12):2927-9
   PubMedGoogle Scholar
• Page NM, Kemp CF, Butlin DJ, Lowry PJ. Placental peptides as markers of gestational disease. Reproduction 2002;123(4):487-95
   PubMed Web of Science ®Google Scholar
• Jauniaux E, Greenwold N, Hempstock J, Burton GJ. Comparison of ultrasonographic and Doppler mapping of the intervillous circulation in normal and abnormal early pregnancies. Fertil Steril 2003;79(1):100-6
   PubMed Web of Science ®Google Scholar
• Fanos V, Antonucci R, Barberini L, et al. Clinical application of metabolomics in neonatology. J Matern Fetal Neonatal Med 2012;25(Suppl 1):104-9
   PubMed Web of Science ®Google Scholar
• Fanos V, Van Den Anker J, Noto A, et al. Metabolomics in neonatology: fact or fiction? Semin Fetal Neonatal Med 2013;18(1):3-12
   PubMed Web of Science ®Google Scholar
• Wilson RD; Genetics Committee of the SOGC. Cell-free fetal DNA in the maternal circulation and its future uses in obstetrics. J Obstet Gynaecol Can 2005;27(1):54-62
   PubMedGoogle Scholar
• Hurst RE. Does the biomarker search paradigm need re-booting? BMC Urol 2009;9:1
   PubMedGoogle Scholar
• Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 2006;24(8):971-83
   PubMed Web of Science ®Google Scholar
• Mischak H, Schanstra JP. CE-MS in biomarker discovery, validation, and clinical application. Proteomics Clin Appl 2011;l5(1-2):9-23
   Google Scholar
• Roscioni SS, De Zeeuw D, Hellemons ME, et al. A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus. Diabetologia 2013;56(2):259-67
   PubMed Web of Science ®Google Scholar
• Metzger J, Negm AA, Plentz RR, et al. Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders. Gut 2013;62(1):122-30
   PubMed Web of Science ®Google Scholar
• Theodorescu D, Schiffer E, Bauer HW, et al. Discovery and validation of urinary biomarkers for prostate cancer. Proteomics Clin Appl 2008;2(4):556-70
   PubMed Web of Science ®Google Scholar
• Mischak H, Allmaier G, Apweiler R, et al. Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med 2010;2(46):46ps42
   PubMed Web of Science ®Google Scholar
• Mischak H, Ioannidis JP, Argiles A, et al. Implementation of proteomic biomarkers: making it work. Eur J Clin Invest 2012;42(9):1027-36
   PubMed Web of Science ®Google Scholar
• Koster MP, Pennings JL, Imholz S, et al. Proteomics and Down syndrome screening: a validation study. Prenat Diagn 2010;30(11):1039-43
   PubMedGoogle Scholar
• Mastricci AL, Akolekar R, Kuppusamy R, et al. Are serum protein biomarkers derived from proteomic analysis useful in screening for trisomy 21 at 11-13 weeks? Fetal Diagn Ther 2011;30(1):53-9
   PubMedGoogle Scholar
• Myers JE, Tuytten R, Thomas G, et al. Integrated proteomics pipeline yields novel biomarkers for predicting preeclampsia. Hypertension 2013;61(6):1281-8
   PubMed Web of Science ®Google Scholar
• Auer J, Camoin L, Guillonneau F, et al. Serum profile in preeclampsia and intra-uterine growth restriction revealed by iTRAQ technology. J Proteomics 2010;73(5):1004-17
   PubMed Web of Science ®Google Scholar
• Michel PE, Crettaz D, Morier P, et al. Proteome analysis of human plasma and amniotic fluid by Off-Gel isoelectric focusing followed by nano-LC-MS/MS. Electrophoresis 2006;27(5-6):1169-81
   PubMedGoogle Scholar
• Michaels JE, Dasari S, Pereira L, et al. Comprehensive proteomic analysis of the human amniotic fluid proteome: gestational age-dependent changes. J Proteome Res 2007;6(4):1277-85
   PubMed Web of Science ®Google Scholar
• Avent ND, Plummer ZE, Madgett TE, et al. Post-genomics studies and their application to non-invasive prenatal diagnosis. Semin Fetal Neonatal Med 2008;13(2):91-8
   PubMed Web of Science ®Google Scholar
• Kolch W, Neususs C, Pelzing M, Mischak H. Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery. Mass Spectrom Rev 2005;24(6):959-77
   PubMed Web of Science ®Google Scholar
• Metzger J, Luppa PB, Good DM, Mischak H. Adapting mass spectrometry-based platforms for clinical proteomics applications: the capillary electrophoresis coupled mass spectrometry paradigm. Crit Rev Clin Lab Sci 2009;46(3):129-52
   PubMed Web of Science ®Google Scholar
• Shen Y, Kim J, Strittmatter EF, et al. Characterization of the human blood plasma proteome. Proteomics 2005;5(15):4034-45
   PubMed Web of Science ®Google Scholar
• Liu B, Qiu FH, Voss C, et al. Evaluation of three high abundance protein depletion kits for umbilical cord serum proteomics. Proteome Sci 2011;9(1):24
   PubMedGoogle Scholar
• Song HJ, Zhang P, Guo XJ, et al. The proteomic analysis of human neonatal umbilical cord serum by mass spectrometry. Acta Pharmacol Sin 2009;30(11):1550-8
   PubMedGoogle Scholar
• Decramer S, Gonzalez De Peredo A, Breuil B, et al. Urine in clinical proteomics. Mol Cell Proteomics 2008;7(10):1850-62
   PubMed Web of Science ®Google Scholar
• Caubet C, Lacroix C, Decramer S, et al. Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease. Pediatr Nephrol 2010;25(1):27-35
   PubMed Web of Science ®Google Scholar
• Thongboonkerd V, Malasit P. Renal and urinary proteomics: current applications and challenges. Proteomics 2005;5(4):1033-42
   PubMed Web of Science ®Google Scholar
• Schaub S, Wilkins J, Weiler T, et al. Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int 2004;65(1):323-32
   PubMed Web of Science ®Google Scholar
• Schiffer E, Mischak H, Novak J. High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS. Proteomics 2006;6(20):5615-27
   PubMed Web of Science ®Google Scholar
• Decramer S, Wittke S, Mischak H, et al. Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat Med 2006;12(4):398-400
   PubMed Web of Science ®Google Scholar
• Carty DM, Siwy J, Brennand JE, et al. Urinary proteomics for prediction of preeclampsia. Hypertension 2011;57(3):561-9
   PubMed Web of Science ®Google Scholar
• Klein J, Lacroix C, Caubet C, et al. Fetal urinary peptides to predict postnatal outcome of renal disease in fetuses with posterior urethral valves (PUV). Sci Transl Med 2013;5(198):198ra106
   PubMed Web of Science ®Google Scholar
• Underwood MA, Gilbert WM, Sherman MP. Amniotic fluid: not just fetal urine anymore. J Perinatol 2005;25(5):341-8
   PubMedGoogle Scholar
• Tsangaris GT, Anagnostopoulos AK, Tounta G, et al. Application of proteomics for the identification of biomarkers in amniotic fluid: are we ready to provide a reliable prediction? EPMA J 2011;2(2):149-55
   PubMedGoogle Scholar
• Heng YJ, Di Quinzio MK, Permezel M, et al. Temporal proteomic analysis of human cervicovaginal fluid with impending term labor. J Proteome Res 2010;9(3):1344-50
   PubMedGoogle Scholar
• Dasari S, Pereira L, Reddy AP, et al. Comprehensive proteomic analysis of human cervical-vaginal fluid. J Proteome Res 2007;6(4):1258-68
   PubMedGoogle Scholar
• Tang LJ, De Seta F, Odreman F, et al. Proteomic analysis of human cervical-vaginal fluids. J Proteome Res 2007;6(7):2874-83
   PubMedGoogle Scholar
• Swamy GK, Simhan HN, Gammill HS, Heine RP. Clinical utility of fetal fibronectin for predicting preterm birth. J Reprod Med 2005;50(11):851-6
   PubMed Web of Science ®Google Scholar
• Shah SJ, Yu KH, Sangar V, et al. Identification and quantification of preterm birth biomarkers in human cervicovaginal fluid by liquid chromatography/tandem mass spectrometry. J Proteome Res 2009;8(5):2407-17
   PubMed Web of Science ®Google Scholar
• Albalat A, Mischak H, Mullen W. Clinical application of urinary proteomics/peptidomics. Expert Rev Proteomics 2011;8(5):615-29
   PubMed Web of Science ®Google Scholar
• Mischak H, Coon JJ, Novak J, et al. Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments. Mass Spectrom Rev 2009;28(5):703-24
   PubMed Web of Science ®Google Scholar
• Henzel WJ, Billeci TM, Stults JT, et al. Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases. Proc Natl Acad Sci USA 1993;90(11):5011-15
   PubMed Web of Science ®Google Scholar
• Henzel WJ, Watanabe C, Stults JT. Protein identification: the origins of peptide mass fingerprinting. J Am Soc Mass Spectrom 2003;14(9):931-42
   PubMedGoogle Scholar
• Issaq HJ, Conrads TP, Prieto DA, et al. SELDI-TOF MS for diagnostic proteomics. Anal Chem 2003;75(7):148A-55A
   Google Scholar
• Check E. Proteomics and cancer: running before we can walk? Nature 2004;429(6991):496-7
   PubMed Web of Science ®Google Scholar
• Baggerly KA, Morris JS, Coombes KR. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics 2004;20(5):777-85
   PubMed Web of Science ®Google Scholar
• Neuhoff N, Kaiser T, Wittke S, et al. Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry. Rapid Commun Mass Spectrom 2004;18(2):149-56
   PubMed Web of Science ®Google Scholar
• Rogers MA, Clarke P, Noble J, et al. Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility. Canc Res 2003;63(20):6971-83
   PubMedGoogle Scholar
• Albrethsen J, Bogebo R, Olsen J, et al. Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum. Clin Chem Lab Med 2006;44(10):1243-52
   PubMed Web of Science ®Google Scholar
• Johannesson N, Wetterhall M, Markides KE, Bergquist J. Monomer surface modifications for rapid peptide analysis by capillary electrophoresis and capillary electrochromatography coupled to electrospray ionization-mass spectrometry. Electrophoresis 2004;25(6):809-16
   PubMedGoogle Scholar
• Gaspar A, Englmann M, Fekete A, et al. Trends in CE-MS. 2005-2006. Electrophoresis 2008;29(1):66-79
   PubMedGoogle Scholar
• Neususs C, Pelzing M, Macht M. A robust approach for the analysis of peptides in the low femtomole range by capillary electrophoresis-tandem mass spectrometry. Electrophoresis 2002;23(18):3149-59
   PubMedGoogle Scholar
• Theodorescu D, Wittke S, Ross MM, et al. Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. Lancet Oncol 2006;7(3):230-40
   PubMed Web of Science ®Google Scholar
• Kaiser T, Kamal H, Rank A, et al. Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation. Blood 2004;104(2):340-9
   PubMed Web of Science ®Google Scholar
• Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 2003;422(6928):198-207
   PubMed Web of Science ®Google Scholar
• Issaq HJ, Conrads TP, Janini GM, Veenstra TD. Methods for fractionation, separation and profiling of proteins and peptides. Electrophoresis 2002;23(17):3048-61
   PubMed Web of Science ®Google Scholar
• Delahunty CM, Yates JR III. MudPIT: multidimensional protein identification technology. Biotechniques 2007;43(5):563, 565, 567 passim
   PubMed Web of Science ®Google Scholar
• Gaspari M, Verhoeckx KC, Verheij ER, Van Der Greef J. Integration of two-dimensional LC-MS with multivariate statistics for comparative analysis of proteomic samples. Anal Chem 2006;78(7):2286-96
   PubMedGoogle Scholar
• Lehotay DC, Hall P, Lepage J, et al. LC-MS/MS progress in newborn screening. Clin Biochem 2011;44(1):21-31
   PubMedGoogle Scholar
• Seger C, Tentschert K, Stoggl W, et al. A rapid HPLC-MS/MS method for the simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human blood samples. Nat Protoc 2009;4(4):526-34
   PubMed Web of Science ®Google Scholar
• Van Den Ouweland JM, Kema IP. The role of liquid chromatography-tandem mass spectrometry in the clinical laboratory. J Chromatogr B Analyt Technol Biomed Life Sci 2012;883-884:18-32
   PubMed Web of Science ®Google Scholar
• Picotti P, Aebersold R. Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat Methods 2012;9(6):555-66
   PubMed Web of Science ®Google Scholar
• Shi T, Su D, Liu T, et al. Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics. Proteomics 2012;12(8):1074-92
   PubMed Web of Science ®Google Scholar
• Huttenhain R, Soste M, Selevsek N, et al. Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics. Sci Transl Med 2012;4(142):142ra194
   Web of Science ®Google Scholar
• Addona TA, Abbatiello SE, Schilling B, et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol 2009;27(7):633-41
   PubMed Web of Science ®Google Scholar
• Agger SA, Marney LC, Hoofnagle AN. Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquid-chromatography-multiple-reaction-monitoring mass spectrometry. Clin Chem 2010;56(12):1804-13
   PubMed Web of Science ®Google Scholar
• Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13(11):913-20
   PubMed Web of Science ®Google Scholar
• Nicolaides KH, Syngelaki A, Ashoor G, et al. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol 2012;207(5):374-e1-6
   PubMedGoogle Scholar
• Fan HC, Blumenfeld YJ, Chitkara U, et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA 2008;105(42):16266-71
   PubMed Web of Science ®Google Scholar
• Chiu RW, Chan KC, Gao Y, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA 2008;105(51):20458-63
   PubMed Web of Science ®Google Scholar
• Busch A, Michel S, Hoppe C, et al. Proteome analysis of maternal serum samples for trisomy 21 pregnancies using ProteinChip arrays and bioinformatics. J Histochem Cytochem 2005;53(3):341-3
   PubMedGoogle Scholar
• Kolialexi A, Tsangaris GT, Papantoniou N, et al. Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma. Prenatal Diagn 2008;28(8):691-8
   PubMed Web of Science ®Google Scholar
• Koster MP, Pennings JL, Imholz S, et al. Bead-based multiplexed immunoassays to identify new biomarkers in maternal serum to improve first trimester Down syndrome screening. Prenatal Diagn 2009;29(9):857-62
   PubMedGoogle Scholar
• Nagalla SR, Canick JA, Jacob T, et al. Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers. J Proteome Res 2007;6(4):1245-57
   PubMedGoogle Scholar
• Cho CK, Smith CR, Diamandis EP. Amniotic fluid proteome analysis from Down syndrome pregnancies for biomarker discovery. J Proteome Res 2010;9(7):3574-82
   PubMedGoogle Scholar
• Cho CK, Drabovich AP, Karagiannis GS, et al. Quantitative proteomic analysis of amniocytes reveals potentially dysregulated molecular networks in Down syndrome. Clin Proteomics 2013;10(1):2
   PubMedGoogle Scholar
• Martinez-Morillo E, Cho CK, Drabovich AP, et al. Development of a multiplex selected reaction monitoring assay for quantification of biochemical markers of down syndrome in amniotic fluid samples. J Proteome Res 2012;11(7):3880-7
   PubMedGoogle Scholar
• Cho CK, Drabovich AP, Batruch I, Diamandis EP. Verification of a biomarker discovery approach for detection of Down syndrome in amniotic fluid via multiplex selected reaction monitoring (SRM) assay. J Proteomics 2011;74(10):2052-9
   PubMed Web of Science ®Google Scholar
• WHO. Available form www.who.int/pmnch/media/news/2012/201204_borntoosoon-report.pdf
   Google Scholar
• Pereira L, Reddy AP, Jacob T, et al. Identification of novel protein biomarkers of preterm birth in human cervical-vaginal fluid. J Proteome Res 2007;6(4):1269-76
   PubMedGoogle Scholar
• Steer PJ. The epidemiology of preterm labour--why have advances not equated to reduced incidence? BJOG 2006;113(Suppl 3):1-3
   PubMedGoogle Scholar
• Buhimschi IA, Christner R, Buhimschi CS. Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. BJOG 2005;112(2):173-81
   PubMedGoogle Scholar
• Buhimschi CS, Bhandari V, Hamar BD, et al. Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis. PLoS Med 2007;4(1):e18
   Google Scholar
• Buhimschi CS, Bhandari V, Han YW, et al. Using proteomics in perinatal and neonatal sepsis: hopes and challenges for the future. Curr Opin Infect Dis 2009;22(3):235-43
   PubMed Web of Science ®Google Scholar
• Medzhitov R. Origin and physiological roles of inflammation. Nature 2008;454(7203):428-35
   PubMed Web of Science ®Google Scholar
• Mercer BM. Preterm premature rupture of the membranes: current approaches to evaluation and management. Obstet Gynecol Clin North Am 2005;32(3):411-28
   PubMed Web of Science ®Google Scholar
• Simhan HN, Canavan TP. Preterm premature rupture of membranes: diagnosis, evaluation and management strategies. BJOG 2005;112(Suppl 1):32-7
   PubMed Web of Science ®Google Scholar
• Edmondson N, Bocking A, Machin G, et al. The prevalence of chronic deciduitis in cases of preterm labor without clinical chorioamnionitis. Pediatr Dev Pathol 2009;12(1):16-21
   PubMedGoogle Scholar
• Tambor V, Kacerovsky M, Andrys C, et al. Amniotic fluid cathelicidin in PPROM pregnancies: from proteomic discovery to assessing its potential in inflammatory complications diagnosis. PLoS ONE 2012;7(7):e41164
   PubMed Web of Science ®Google Scholar
• Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005;330(7491):565
   PubMed Web of Science ®Google Scholar
• Bujold E, Roberge S, Lacasse Y, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010;116(2 Pt 1):402-14
   PubMed Web of Science ®Google Scholar
• Hofmeyr GJ, Duley L, Atallah A. Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and commentary. BJOG 2007;114(8):933-43
   PubMed Web of Science ®Google Scholar
• Buhimschi IA, Zhao G, Funai EF, et al. Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia. Am J Obstet Gynecol 2008;199(5):551-e1-e16
   PubMedGoogle Scholar
• Chen G, Zhang Y, Jin X, et al. Urinary proteomics analysis for renal injury in hypertensive disorders of pregnancy with iTRAQ labeling and LC-MS/MS. Proteomics Clin Appl 2011;5(5-6):300-10
   PubMed Web of Science ®Google Scholar
• Watanabe H, Hamada H, Yamada N, et al. Proteome analysis reveals elevated serum levels of clusterin in patients with preeclampsia. Proteomics 2004;4(2):537-43
   PubMed Web of Science ®Google Scholar
• Shin JK, Han KA, Kang MY, et al. Expression of clusterin in normal and preeclamptic placentas. J Obstet Gynaecol Res 2008;34(4):473-9
   PubMed Web of Science ®Google Scholar
• Blumenstein M, Mccowan LM, Wu S, et al. SCOPE Consortium. Plasma clusterin increased prior to small for gestational age (SGA) associated with preeclampsia and decreased prior to SGA in normotensive pregnancies. Reprod sci 2012;19(6):650-7
   PubMedGoogle Scholar
• Kolla V, Jeno P, Moes S, et al. Quantitative proteomic (iTRAQ) analysis of 1st trimester maternal plasma samples in pregnancies at risk for preeclampsia. J Biomed Biotechnol 2012;2012:305964
   Google Scholar
• Rasanen J, Girsen A, Lu X, et al. Comprehensive maternal serum proteomic profiles of preclinical and clinical preeclampsia. J Proteome Res 2010;9(8):4274-81
   PubMedGoogle Scholar
• Iniguez G, Argandona F, Medina P, et al. Acid-labile subunit (ALS) gene expression and protein content in human placentas: differences according to birth weight. J Clin Endocrinol Metab 2011;96(1):187-91
   PubMed Web of Science ®Google Scholar
• Park J, Cha DH, Lee SJ, et al. Discovery of the serum biomarker proteins in severe preeclampsia by proteomic analysis. Exp Mol Med 2011;43(7):427-35
   PubMedGoogle Scholar
• Chatelain P. Children born with intra-uterine growth retardation (IUGR) or small for gestational age (SGA): long term growth and metabolic consequences. Endocr Regul 2000;34(1):33-6
   PubMedGoogle Scholar
• Conde-Agudelo A, Papageorghiou AT, Kennedy SH, Villar J. Novel biomarkers for predicting intrauterine growth restriction: a systematic review and meta-analysis. BJOG 2013;120(6):681-94
   PubMed Web of Science ®Google Scholar
• Wolter M, Rower C, Koy C, et al. A proteome signature for intrauterine growth restriction derived from multifactorial analysis of mass spectrometry-based cord blood serum profiling. Electrophoresis 2012;33(12):1881-93
   PubMedGoogle Scholar
• Cecconi D, Lonardoni F, Favretto D, et al. Changes in amniotic fluid and umbilical cord serum proteomic profiles of foetuses with intrauterine growth retardation. Electrophoresis 2011;32(24):3630-7
   PubMedGoogle Scholar
• Chang CP, Mcdill BW, Neilson JR, et al. Calcineurin is required in urinary tract mesenchyme for the development of the pyeloureteral peristaltic machinery. J Clin Invest 2004;113(7):1051-8
   PubMedGoogle Scholar
• Klein J, Gonzalez J, Miravete M, et al. Congenital ureteropelvic junction obstruction: human disease and animal models. Int J Exp Pathol 2011;92(3):168-92
   PubMed Web of Science ®Google Scholar
• Decramer S, Bascands JL, Schanstra JP. Non-invasive markers of ureteropelvic junction obstruction. World J Urol 2007;25(5):457-65
   PubMedGoogle Scholar
• Decramer S, Zurbig P, Wittke S, et al. Identification of urinary biomarkers by proteomics in newborns: use in obstructive nephropathy. Contrib Nephrol 2008;160:127-41
   PubMed Web of Science ®Google Scholar
• Drube J, Zurbig P, Schiffer E, et al. Urinary proteome analysis identifies infants but not older children requiring pyeloplasty. Pediatr Nephrol 2010;25(9):1673-8
   PubMed Web of Science ®Google Scholar
• Bandin F, Siwy J, Breuil B, et al. Urinary proteome analysis at 5-year followup of patients with nonoperated ureteropelvic junction obstruction suggests ongoing kidney remodeling. J Urol 2012;187(3):1006-11
   PubMed Web of Science ®Google Scholar
• Mesrobian HG. The value of newborn urinary proteome analysis in the evaluation and management of ureteropelvic junction obstruction: a cost-effectiveness study. World J Urol 2009;27(3):379-83
   PubMedGoogle Scholar
• Harambat J, Van Stralen KJ, Kim JJ, Tizard EJ. Epidemiology of chronic kidney disease in children. Pediatr Nephrol 2012;27(3):363-73
   PubMed Web of Science ®Google Scholar
• Morris RK, Quinlan-Jones E, Kilby MD, Khan KS. Systematic review of accuracy of fetal urine analysis to predict poor postnatal renal function in cases of congenital urinary tract obstruction. Prenatal Diagn 2007;27(10):900-11
   PubMed Web of Science ®Google Scholar
• Morris RK, Malin GL, Khan KS, Kilby MD. Antenatal ultrasound to predict postnatal renal function in congenital lower urinary tract obstruction: systematic review of test accuracy. BJOG 2009;116(10):1290-9
   PubMed Web of Science ®Google Scholar
• Hogan J, Dourthe ME, Blondiaux E, et al. Renal outcome in children with antenatal diagnosis of severe CAKUT. Pediatr Nephrol 2012;27(3):497-502
   PubMedGoogle Scholar
• Lopez Pereira P, Martinez Urrutia MJ, Jaureguizar E. Initial and long-term management of posterior urethral valves. World J Urol 2004;22(6):418-24
   PubMedGoogle Scholar
• Nasir AA, Ameh EA, Abdur-Rahman LO, et al. Posterior urethral valve. World J pediatr 2011;7(3):205-16
   PubMedGoogle Scholar
• Siwy J, Mullen W, Golovko I, et al. Human urinary peptide database for multiple disease biomarker discovery. Proteomics Clin Appl 2011;5(5-6):367-74
   PubMed Web of Science ®Google Scholar
• Von Zur Muhlen C, Schiffer E, Zuerbig P, et al. Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients. J Proteome Res 2009;8(1):335-45
   PubMed Web of Science ®Google Scholar
• Zimmerli LU, Schiffer E, Zurbig P, et al. Urinary proteomic biomarkers in coronary artery disease. Mol Cell Proteomics 2008;7(2):290-8
   PubMed Web of Science ®Google Scholar
• Weinstein LS, Xie T, Zhang QH, Chen M. Studies of the regulation and function of the Gs alpha gene GNAS using gene targeting technology. Pharmacol Ther 2007;115(2):271-91
   PubMedGoogle Scholar
• Kelsey G. Epigenetics and imprinted genes: insights from the imprinted GNAS locus. Hormone Res 2009;71(Suppl 2):22-9
   PubMedGoogle Scholar
• EURenOmics. Available form www.eurenomics.com
   Google Scholar
• Molina F, Dehmer M, Perco P, et al. Systems biology: opening new avenues in clinical research. Nephrol Dial Transplant 2010;25(4):1015-18
   PubMed Web of Science ®Google Scholar
• Dominiczak AF, Herget-Rosenthal S, Delles C, et al. Systems biology to battle vascular disease. Nephrol Dial Transplant 2010;25(4):1019-22
   PubMed Web of Science ®Google Scholar